Publication Date:
This advisory introduces readers to digital therapeutics (DTx) and the benefits of their use in behavioral health. It describes the research, regulatory, and reimbursement implications for DTx as well as selection and implementation considerations.
Publication Date:
This advisory discusses the epidemiology of the mental health symptoms and conditions of Long COVID, provides evidence-based resources for the treatment of those conditions, and offers possible resources.
Publication Date:
This advisory introduces readers to cannabidiol (CBD), how it is derived, and how it differs from delta-9 THC and other cannabinoids. The advisory focuses on the risks and harms of CBD, especially those sold over the counter. This advisory also clarifies common misconceptions about CBD, given its broad availability and marketing for several medical conditions despite limited evidence of efficacy.
Publication Date:
This resource provides information to primary care providers and practices on how to implement opioid use disorder treatment using buprenorphine. It identifies common barriers and strategies to overcome them. It documents step-by-step tactics to support buprenorphine implementation.
Publication Date:
This guide reviews ways that telehealth modalities can be used to provide treatment for serious mental illness and substance use disorders among adults, distills the research into recommendations for practice, and provides examples of how these recommendations can be implemented.
Publication Date:
This guide helps health care providers, systems, and communities support recovery from substance use disorders via employment mechanisms. It describes relevant research, examines emerging and best practices, identifies knowledge gaps and implementation challenges, and offers resources.
Publication Date:
This Advisory is based on TIP 53, Addressing Viral Hepatitis in People with Substance Use Disorders. It offers guidance to providers and administrators in substance use disorder treatment programs on screening for, and treating clients with, hepatitis A, hepatitis B, and hepatitis C infections.
Publication Date:
This Advisory is based on TIP 50, Addressing Suicidal Thoughts and Behaviors in Substance Abuse Treatment. It provides strategies for identifying and addressing suicidal thoughts and behaviors among individuals with substance use disorders (SUDs).
Publication Date:
This guide reviews interventions for people living with substance use and mental disorders who are at risk for or living with HIV. Selected interventions are in alignment with goals of the federal “Ending the HIV Epidemic: A Plan for America” (EHE) initiative.
Publication Date:
This guide supports health care providers, systems, and communities seeking to treat stimulant use disorders. It describes relevant research findings, examines emerging and best practices, identifies knowledge gaps and implementation challenges, and offers useful resources.
Publication Date:
This guide discusses the challenges in care transitions and the need for better care practices and care coordination from inpatient to outpatient behavioral health care, and presents feasible, evidence-based practices that health systems and providers can take to improve patient connection and safety during inpatient to outpatient transition, and provides recommendations specific to both inpatient and outpatient settings.
Publication Date:
Zero Suicide operationalizes the core components necessary for health care systems to transform suicide care into seven elements. Within each element section, find a description of what each element is, why it is necessary to Zero Suicide implementation, a summary of supporting research, and key readings and tools. Use the navigation bar that appears at the top of each element page to jump between sections.
Publication Date:
The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management is intended to aid clinicians in their clinical decision-making and management of patients experiencing alcohol withdrawal syndrome.
Publication Date:
This guide developed by the American Society of Addiction Medicine (ASAM) provides healthcare providers with instant access to current guidelines in a clear concise format.
Publication Date:
This guide examines a wide range of evidence-based practices for screening and assessment of people in the justice system who have co-occurring mental and substance use disorders.
Publication Date:
This tool guides clinicians through a series of questions to identify risky substance use in their adult patients. The accompanying resources assist clinicians in providing patient feedback and arranging for specialty care, where necessary, using the 5 As of intervention.
Publication Date:
This resource places the selection of programs and practices within the broader context of evidence-based prevention.
Publication Date:
This toolkit supports a structured, team-based approach to improving the management of patients who take opioids to ease chronic pain.
Publication Date:
This pocket guide was produced by the American Society of Addiction Medicine (ASAM) and the National Association of Drug Court Professionals (NADCP) and is designed to help counselors and therapists working with drug court participants refer and link participants to opioid treatment services in outpatient offices, clinics, and Opioid Treatment Programs (OTPs).
Publication Date:
This pocket guide was produced by the American Society of Addiction Medicine (ASAM) and the National Association of Drug Court Professionals (NADCP) guide.
Publication Date:
Developed by AHRQ, this report reviews the scientific and grey literature about implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care settings.
Publication Date:
This AHRQ environmental scan lists tools and resources for the implementation of medication-assisted treatment (MAT) in a wide variety of settings.
Publication Date:
The purpose of this systematic review is to evaluate treatments for adults with schizophrenia.
Publication Date:
The American Society of Addiction Medicine (ASAM) developed this pocket guide for healthcare providers which provides instant access to key information in The ASAM Appropriate Use of Testing in Clinical Addiction Medicine in a clear and concise format.
Publication Date:
This technical package represents a select group of strategies based on the best available evidence to help communities and states sharpen their focus on prevention activities with the greatest potential to prevent suicide.
Displaying 1 - 25 out of 50